Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TCP-c Inhibitors

The chemical class of TCP-c Inhibitors encompasses a diverse range of compounds that indirectly target the TCP-c protein through various signaling pathways and cellular processes. This class primarily consists of kinase inhibitors, reflecting the critical role of kinase-mediated signaling in regulating TCP-c's function. Sorafenib and Sunitinib, for instance, are multi-kinase inhibitors that could modify several pathways potentially connected to TCP-c, highlighting the intertwined nature of signaling networks within cells.

Imatinib and Dasatinib, targeting specific tyrosine kinases, underscore the significance of these enzymes in the regulation of proteins like TCP-c. Their role in this class suggests that TCP-c activity could be modulated through precise intervention in tyrosine kinase signaling.

The inclusion of mTOR inhibitors like Everolimus points to the importance of cell growth and survival pathways in the regulation of TCP-c. This indicates that TCP-c might play a role in cellular processes governed by mTOR signaling. Similarly, EGFR inhibitors such as Gefitinib and Erlotinib hint at a possible connection between epidermal growth factor signaling and TCP-c function.

Crizotinib's role in this class, targeting ALK and MET receptors, further illustrates the complexity of the signaling networks associated with TCP-c. The presence of Pazopanib, a multi-kinase inhibitor affecting VEGF pathways, implies that angiogenesis and vascular growth signaling could intersect with TCP-c's regulatory mechanisms.

Lapatinib and Vandetanib, targeting multiple receptor tyrosine kinases, emphasize the broad spectrum of signaling pathways that could be leveraged to modulate TCP-c activity. The diversity of this chemical class reflects the multifaceted nature of cellular signaling and underscores the potential of these inhibitors to provide insights into TCP-c's biological role.

In summary, the TCP-c Inhibitors class represents a strategic and diverse array of chemicals aimed at elucidating the function of TCP-c by targeting various signaling pathways. This class is instrumental for researchers exploring the intricate web of cellular processes in which TCP-c is involved, offering a window into the protein's regulation and potential biological significance.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A kinase inhibitor, may influence pathways intersecting with TCP-c's function, altering its activity.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Targets tyrosine kinases, potentially modulating signaling pathways that intersect with TCP-c.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$197.00
$520.00
$1093.00
4
(1)

A receptor tyrosine kinase inhibitor, could affect signaling cascades relevant to TCP-c regulation.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

An mTOR inhibitor, could modulate cell growth pathways linked with TCP-c activity.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

A multi-kinase inhibitor, might alter vascular endothelial growth factor pathways intersecting with TCP-c.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

An EGFR inhibitor, could influence epidermal growth factor signaling linked to TCP-c.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

Another EGFR inhibitor, possibly affects similar pathways as Gefitinib, impacting TCP-c.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

A Src-family kinase inhibitor, might modulate signaling pathways influencing TCP-c activity.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Inhibits BCR-ABL tyrosine kinase, potentially affecting signaling cascades relevant to TCP-c.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Targets EGFR and HER2, could indirectly modulate TCP-c through these pathways.